Minimally Invasive Thoracic Surgery Market Report 2026

Minimally Invasive Thoracic Surgery Market Overview

• Minimally Invasive Thoracic Surgery market size has reached to $4.38 billion in 2025 • Expected to grow to $6.46 billion in 2030 at a compound annual growth rate (CAGR) of 8.1% • Growth Driver: The Rising Incidence Of Lung Diseases Is Fueling The Growth Of The Market Due To The Increasing Need More Effective Surgical Treatments • Market Trend: Advancements In Robotic-Assisted Minimally Invasive Thoracic Surgery For Enhanced Precision And Outcomes • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Minimally Invasive Thoracic Surgery Market?

Minimally invasive thoracic surgery (MITS) is a technique that performs chest procedures through small incisions using specialized instruments, aiming to reduce bodily trauma and postoperative discomfort. This approach shortens hospital stays, speeds up recovery, and offers greater precision and visibility than traditional open surgery, ultimately improving surgical outcomes and minimizing complications. The main types of minimally invasive thoracic surgery are lobectomy, wedge resection, pneumonectomy, and others. A lobectomy is a surgical procedure that involves removing an entire lobe of an organ, most commonly a lung, to treat disease or damage. It includes various products such as energy devices, instruments, staplers and disposables, and visualization systems with several procedural types, including video-assisted thoracoscopic surgery (VATS), robotic-assisted thoracic surgery, endoscopic thoracic surgery, and others. These procedures are performed for various applications, such as lung cancer surgery, esophageal surgery, mediastinal surgery, and others, and are used by several end users, including hospitals, specialty clinics, ambulatory surgical centers, and others.

What Is The Minimally Invasive Thoracic Surgery Market Growth Forecast?

The minimally invasive thoracic surgery market size is expected to see strong growth in the next few years. It will grow to $6.46 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to increasing adoption of next-generation robotic platforms, rising integration of AI-guided surgical planning, expansion of outpatient thoracic surgery programs, growing demand for high-definition imaging systems, increasing focus on outcome-based surgical care. Major trends in the forecast period include increasing adoption of robotic-assisted thoracic procedures, rising use of advanced visualization systems, growing preference for video-assisted techniques, expansion of precision energy devices, enhanced focus on reduced postoperative recovery time.

What Is The Driver Of The Minimally Invasive Thoracic Surgery Market?

The rising incidence of lung diseases is expected to propel the growth of the minimally invasive thoracic surgery market going forward. Lung diseases are medical conditions that impair lung function and breathing, such as asthma, COPD, pneumonia, and lung cancer. Lung disease is rising largely due to tobacco smoking because the harmful chemicals in tobacco damage lung cells’ DNA over time, increasing the likelihood of uncontrolled cell growth and tumor formation. Minimally invasive treatment helps lung disease patients by targeting and removing or destroying tumors through small incisions or imaging-guided probes, which reduces recovery time, minimizes damage to healthy lung tissue, lowers the risk of complications, and allows patients to resume normal activities sooner. For instance, in June 2025, according to the Centers for Disease Control and Prevention, a US-based government administration, in 2022, the United States recorded 218,893 new cases of lung cancer, and in 2023, lung cancer claimed the lives of 131,584 people in the country. Therefore, the rising incidence of lung diseases is driving the growth of the minimally invasive thoracic surgery industry.

Key Players In The Global Minimally Invasive Thoracic Surgery Market

Major companies operating in the minimally invasive thoracic surgery market are Johnson And Johnson Services Inc., Medtronic Plc, Koninklijke Philips N.V., Stryker Corporation, GE Healthcare Inc., Olympus Corporation, Intuitive Surgical Operations Inc., Smith & Nephew plc, Teleflex Incorporated, Karl Storz SE & Co. KG, Cook Group Incorporated, CONMED Corporation, Applied Medical Resources Corporation, KLS Martin Group, Aesculap Inc., Medela Inc., Richard Wolf GmbH, B. Braun Melsungen AG, Ackermann Instrumente GmbH, Cmr Surgical, Genesee Biomedical Inc.

Global Minimally Invasive Thoracic Surgery Market Trends and Insights

Major companies operating in the minimally invasive thoracic surgery market are focusing on developing innovative technology such as the robotic-assisted surgery platform to improve surgical accuracy and enhance overall clinical outcomes. A robotic-assisted surgery platform is a surgical system where surgeons control robotic arms to perform minimally invasive procedures with high precision, enhancing accuracy, dexterity, and visualization compared to traditional surgery. For instance, in June 2024, Monmouth Medical Centre (MMC), a US-based medical institution, introduced the Ion Robotic platform, the Aliya PEF system, and intraoperative AI-driven CT imaging. It offers benefits such as enhanced surgical precision, better patient outcomes, and real-time imaging to support improved decision-making. These technologies collectively enable minimally invasive, accurate lung cancer diagnosis and treatment with faster recovery and superior outcomes. They provide real-time navigation, non-thermal tumor ablation, and reduced radiation exposure, promoting early detection and effective care.

What Are Latest Mergers And Acquisitions In The Minimally Invasive Thoracic Surgery Market?

In August 2024, KARL STORZ Endoscopy America Inc., a US-based company that offers endoscopic equipment, acquired Asensus Surgical Inc. for $0.35 per share in cash. With this acquisition, KARL STORZ aims to enhance its technological capabilities in digital and robotic-assisted minimally invasive thoracic surgery by integrating advanced performance-guided surgery platforms. Asensus Surgical Inc. is a US-based medical device company that offers a robotic-assisted platform designed for minimally invasive thoracic procedures.

What Defines the Minimally Invasive Thoracic Surgery Market?

The minimally invasive thoracic surgery (MITS) market consists of revenues earned by entities by providing services such as diagnostic endoscopy, preoperative imaging, intraoperative navigation support, postoperative care coordination, and tele-consultation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The minimally invasive thoracic surgery market also includes sales of energy-based dissection devices, robotic surgical arms, single-use staplers, and ultrasound-guided instrument accessories. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Minimally Invasive Thoracic Surgery Market Report 2026?

The minimally invasive thoracic surgery market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the minimally invasive thoracic surgery industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.